Glaucoma medications
ocular hypotensive, hypotensive
HYPOTENSIVE
Both treatment groups achieved significant reductions in topical ocular medication use at all postoperative time points (Topical ocular medication use over the course of Year 1. At the preoperative visit in Group 1, no eyes were receiving 0 or 1 medication, while 94.2% of eyes were using 3–4 medications (Fig. Proportion of eyes with categorical ocular hypotensive medication use in group 1 (Phacoemulsification + ECP). Proportion of eyes with categorical ocular hypotensive medication use in group 2 (Phacoemulsification + ECP + iStent Both treatment groups demonstrated high proportions of eyes with reductions in topical ocular hypotensive medication use throughout follow-up (Fig. Change in categorical topical ocular medication use vs preoperative over the course of Year 1